Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Category Archives: News & Announcements 2020

December 31, Top 20 Shareholders

News & Announcements 2020, Top 20 ShareholdersBy Richard MollardJanuary 4, 2021

201231_Top_Holders_Report (91)

December 23, PharmAust Commences MPL Manufacture for Human Clinical Trials

News & Announcements 2020By Richard MollardDecember 23, 2020

201223_PAA_Syngene_FightMND_Manufacture

December 22, PharmAust Set to Commence Phase IIb Anticancer Canine Trial

News & Announcements 2020By Richard MollardDecember 22, 2020

201222_PhaseIIbcaninetrial

December 21, Epichem Awarded DNDi Extension

News & Announcements 2020By Richard MollardDecember 21, 2020

201221_EpichemDNDi

December 4, Issued Capital

News & Announcements 2020By Richard MollardDecember 4, 2020

201204_IssuedCapital

November 30, Top 20 Shareholders

News & Announcements 2020, Top 20 ShareholdersBy Richard MollardDecember 1, 2020

201130_Top_Holders_Report

November 5, AGM Results

News & Announcements 2020By Richard MollardNovember 5, 2020

201105_AnnualGeneralMeeting

October 31, Top 20 Shareholders

News & Announcements 2020, Top 20 ShareholdersBy Richard MollardNovember 2, 2020

201031_Top_Holders_Report (87)

2020 Annual General Meeting Notice

News & Announcements 2020By Richard MollardOctober 2, 2020

201002_2020_Annual General Meeting

September 30, Top 20 Shareholders

News & Announcements 2020, Top 20 ShareholdersBy Richard MollardOctober 1, 2020

Top_Holders_Report (84)

12345
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on TwitterPharmAust Retweeted
FightMNDF I G H T M N D@FightMND·
10h

Here's a perfect example of how we put your Big Freeze beanie purchases and donations to work in the fight against MND.

A new Australian clinical trial testing a cancer drug to treat MND is set to begin next month thanks to direct funding from FightMND.

https://fal.cn/3oVF4

Reply on Twitter 1529714129090527232Retweet on Twitter 15297141290905272322Like on Twitter 152971412909052723211Twitter 1529714129090527232
Load More...
Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top